Applied Biosciences Corp. (APPB)
OTCQB OTCQB Primary Summary
Applied Biosciences Corp. (APPB) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Applied Biosciences Corp. ever had a stock split?
Applied Biosciences Corp. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Christopher Michael Bridges CEO | OTCQB Exchange | 03815L102 CUSIP |
| US Country | 25 Employees | - Last Dividend | 24 Oct 2016 Last Split | - IPO Date |
Overview
Applied Biosciences Corp. is at the forefront of developing and bringing to market synthetic cannabinoid therapeutics and biopharmaceuticals. Its focus is aimed at the endocannabinoid system, aiming to treat a wide array of diseases through various therapeutic areas. Since its incorporation in 2014, with its headquarters in Beverly Hills, California, the company has ventured into utilizing advancements in cannabinoid research for medical and health and wellness purposes. Beyond its biopharmaceutical pursuits, it extends its reach into the consumer sphere, providing THC-free CBD products designed for overall health and wellbeing, enhancing its market presence through value-added services like testing and analytics.
Products and Services
- Synthetic Cannabinoid Therapeutics/Biopharmaceuticals
Applied Biosciences Corp. specializes in the development and commercialization of synthetic cannabinoid-based therapeutics and biopharmaceuticals. These products are carefully engineered to target the endocannabinoid system, showing potential in treating a multitude of diseases across various therapeutic areas. The enterprise leverages cutting-edge science and research to provide solutions that could revolutionize how certain illnesses are treated.
- Consumer and OTC THC-free CBD Products
The company also offers a range of consumer-focused THC-free CBD products, catered towards promoting overall health and wellbeing. These products include, but are not limited to, dietary supplements, topicals, and other wellness products that harness the benefits of CBD without the psychoactive effects associated with THC. Aimed at the health-conscious consumer, these products underscore Applied Bioscience Corp.'s commitment to providing alternative health solutions.
- Testing and Analytics Capabilities
Enhancing its suite of offerings, Applied Biosciences Corp. delivers testing and analytics services to its customers. This aspect of the company underscores the importance of quality control and reliability in the cannabinoid market, providing essential insights into product composition and safety. These services are not only beneficial for ensuring compliance with regulations but also add an extra layer of trust and transparency for consumers and partners alike.
